The FDA confirmed in February 2025 that compounded semaglutide remains legal through 503A pharmacies for patients with documented medical need (allergy, non-commercial strength, or different delivery route), but warned 30 telehealth companies against illegal marketing of compounded GLP-1s [3]
However, research shows that lean mass loss can be significantly mitigated through resistance training and adequate protein intake during GLP-1 therapy
Quantitative real-time PCR (RTqPCR) was performed using SYBR Green PCR master mix (Applied Biosystems, 4309155) with QuantStudio 7 Flex (Applied Biosystems)
One class of drugs that has gained significant attention in this context is the glucagon-like peptide-1 (GLP-1) receptor agonists
Crucially, physical exercise and toxic exposures can produce significant changes in the levels of antioxidants, particularly GSH, in various regions of the brain (32)
Yonghui Dong, Dr